Table 2.
Performance in predicting drug indications. Reported is AUPRC
| Category | KL | JS | Proximity | DSD | RGCN | HAN | HGT | BioBERT | TxGNN | COMIC |
|---|---|---|---|---|---|---|---|---|---|---|
| Random | 0.50 | 0.49 | 0.53 | 0.49 | 0.84 | 0.87 | 0.72 | 0.81 | 0.91 | 0.9375 |
| Cell proliferation | 0.51 | 0.50 | 0.47 | 0.51 | 0.47 | 0.65 | 0.61 | 0.83 | 0.92 | 0.9031 |
| Mental health | 0.50 | 0.50 | 0.44 | 0.50 | 0.55 | 0.61 | 0.56 | 0.64 | 0.89 | 0.9046 |
| cardiovascular | 0.49 | 0.50 | 0.50 | 0.50 | 0.41 | 0.63 | 0.60 | 0.66 | 0.64 | 0.8817 |
| Anemia | 0.47 | 0.53 | 0.49 | 0.51 | 0.42 | 0.67 | 0.53 | 0.64 | 0.96 | 0.9302 |
| Adrenal gland | 0.48 | 0.50 | 0.48 | 0.50 | 0.38 | 0.59 | 0.54 | 0.64 | 0.99 | 0.9375 |
| Autoimmune | 0.51 | 0.49 | 0.56 | 0.52 | 0.51 | 0.53 | 0.49 | 0.66 | 0.87 | 0.9284 |
| Metabolic disorder | 0.51 | 0.54 | 0.41 | 0.51 | 0.67 | 0.56 | 0.54 | 0.68 | 0.76 | 0.9362 |
| Diabetes | 0.50 | 0.52 | 0.47 | 0.52 | 0.40 | 0.67 | 0.62 | 0.69 | 0.87 | 0.9114 |
| Neurodegenerative | 0.50 | 0.51 | 0.49 | 0.51 | 0.84 | 0.71 | 0.60 | 0.57 | 0.95 | 0.9182 |